| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 24.05.
| Watson Pharma (WPI) Confirms Patent Challenge on Testim from Auxilium | | - | StreetInsider.com |
| 24.05.
| Duke Energy, Watson Pharma: Overlooked M&A Stocks | | - | The Street |
| 24.05.
| Watson Pharma rises on Wells Fargo analyst upgrade | | - | Yahoo-USA |
| 24.05.
| Upgrade Alert for Watson Pharmaceuticals | | - | SmarTrend |
| 23.05.
| WCRX, Watson Pharma in Legal Tussle | | 1 | Zacks |
| 22.05.
| Uptrend Call Working As Watson Pharmaceuticals Stock Rises 17.3% | | 1 | SmarTrend |
| 18.05.
| The Zacks Analyst Blog Highlights: Watson Pharmaceuticals, Shire, Depomed, Comcast and Microsoft | | 71 | PR Newswire |
| CHICAGO, May 18, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Watson Pharmaceuticals, Shire, Depomed, Comcast and Microsoft | |
| 15.05.
| Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. -- Increased Sales Driving Generic Drug Makers Higher | | 16 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 05/15/12 -- www.shinesrooms.com has a handpicked team of market professionals with over 100 years of combined investing experience. Today they are providing members...
Mehr lesen zu:
Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. -- Increased Sales Driving Generic Drug Makers Higher | |
| 15.05.
| Watson Pharmaceuticals Has Returned 18.5% Since SmarTrend Recommendation | | - | SmarTrend |
| 10.05.
| Watson Pharma Confirms Lialda Patent Challenge | | 69 | AFX News |
| WASHINGTON (dpa-AFX) - Watson Pharmaceuticals, Inc. (WPI) confirmed
Wednesday that its subsidiary, Watson Laboratories, Inc. - Florida, has filed an
Abbreviated New Drug Application with...
Mehr lesen zu:
Watson Pharma Confirms Lialda Patent Challenge | |
| 09.05.
| Watson Pharma (WPI) Forms Global Integration Manangement Office to Support Actavis Purchase | | 6 | StreetInsider.com |
| 07.05.
| Uptrend Call Working As Watson Pharmaceuticals Stock Rises 22.7% | | - | SmarTrend |
| 01.05.
| Watson Pharmaceuticals To Webcast Annual Meeting Of Stockholders On May 11, 2012 | | 19 | PR Newswire |
| PARSIPPANY, N.J., May 1, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) announced today that the Company will conduct a live webcast of its 2012 Annual Meeting of Stockholders...
Mehr lesen zu:
Watson Pharmaceuticals To Webcast Annual Meeting Of Stockholders On May 11, 2012 | |
| 30.04.
| Watson Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript | | - | Seeking Alpha |
| 30.04.
| Watson Pharmaceuticals Beats on Both Top and Bottom Lines | | 1 | Motley Fool |
| 30.04.
| Watson Pharma Tops Estimates, Boosts Forecast On Generics | | 34 | AFX News |
| WASHINGTON (dpa-AFX) - Watson Pharmaceuticals, Inc. (WPI) on Monday reported
a significant increase in first-quarter profit, as new generic drug launches and
improved overseas performance...
Mehr lesen zu:
Watson Pharma Tops Estimates, Boosts Forecast On Generics | |
| 30.04.
| Watson Pharmaceuticals steigert Umsatz und Gewinn | | 74 | BörseGo |
| Parsipanny (BoerseGo.de) - Watson Pharmaceuticals hat in den ersten drei Monaten des Jahres Umsatz und Gewinn im Jahresvergleich deutlich gesteigert und die Prognosen der Analysten übertroffen. Wie...
Mehr lesen zu:
Watson Pharmaceuticals steigert Umsatz und Gewinn | |
| 30.04.
| Watson Pharma Q1 Profit Climbs; Revises 2012 View | | 35 | AFX News |
| WASHINGTON (dpa-AFX) - Watson Pharmaceuticals Inc. (WPI) reported a rise in
first-quarter 2012 net income attributable to common shareholders to $54.8
million or $0.43 per share from $45.3...
Mehr lesen zu:
Watson Pharma Q1 Profit Climbs; Revises 2012 View | |
| 30.04.
| Watson Pharma profit rises 21% | | 1 | MarketWatch |
| 30.04.
| Watson Pharmaceuticals: Acquisition Of Actavis Creates A Lot Of Value | | 1 | Seeking Alpha |
